Aardvark Therapeutics (AARD) Shares Issued (2024 - 2025)
Aardvark Therapeutics (AARD) reported Shares Issued of $3.0 million for Q4 2025, up 206.58% on a YoY basis from $991058.0 in Q4 2024, and up 206.58% sequentially from $991058.0 in Q4 2024.
Aardvark Therapeutics (AARD) Shares Issued (2024 - 2025) Analysis & Trends
Aardvark Therapeutics (AARD) has 2 years of Shares Issued data on file, last reported at $3.0 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Issued rose 206.58% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2025 stood at $3.0 million (up 206.58% YoY), and the FY2025 full-year result was $3.0 million, up 206.58% from the prior year.
- Shares Issued advanced to $3.0 million in Q4 2025, from $991058.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $3.0 million in Q4 2025 to a low of $991058.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 991,058.00 |
| Dec 31, 2024 | 991,058.00 |